Chitosan Chewing Gum Study in Dialysis Patients

University of Maryland Baltimore (UMB)

Status: Completed

Conditions: End Stage Renal Disease

Treatments: Dietary Supplement: Chitosan

Study type: Observational

Funder types: Other

Identifiers

NCT01770470

HP-00045129

Details and patient eligibility

About

The purpose of the pilot study is to determine the impact of short-term administration of chitosan-containing chewing gum on phosphate levels in patients with elevated serum phosphate levels.

Full description

The impact of using salivary phosphate binders in ESRD patients is not fully known. The purpose of the pilot study is to determine the impact of short-term administration of chitosan-containing chewing gum on phosphate levels in patients with elevated serum phosphate levels.

Enrollment: 15 patients

Sex: All

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18-64 years old
• ESRD receiving hemodialysis
• serum phosphate > 6.0 mg/dL

Exclusion criteria

• Unable to sign consent

Trial design

15 participants in 1 patient group

Patients receiving chronic hemodialysis

Description:

Dialysis patients chewing chitosan-containing gum

Treatment:

Dietary Supplement: Chitosan